1. Introduction {#sec1}
===============

The outbreak of COVID-19 has lasted for several months and spread to the world, WHO had called it pandemic. Because COVID-19 is extremely infectious, and people still have little knowledge about the disease in the early stage of the epidemic, no effective measures have been taken to stop the spread of the virus, so a large number of people have been infected in a short period of time. Compared with a large number of patients, the number of medical staff is obviously insufficient, so they have to increase the number of shifts to deal with this situation. The overloaded work intensity has a strong impact on the physical and psychological health of medical staff. In addition, frequent shift work disrupts the continuity of treatment. It is reported that there are varying degrees of psychological and sleep disorders in the frontline medical staff\[[@bib1],[@bib2]\], but there are few reports on the impact of the night shift schedule of medical staff on medical treatment during the epidemic. This study compares the treatment of patients admitted before and after the night shift schedule changed, and explores the relationship between the improved night shift schedule and the mortality of critically ill patients with COVID-19.

2. Methods {#sec2}
==========

2.1. Study design and participants {#sec2.1}
----------------------------------

This single-center, retrospective, observational study was done at Wuhan Union Hospital (Wuhan, China). We retrospectively analysed patients from Jan 24, 2020, to Mar 26, 2020, who had been diagnosed with COVID-19, according to WHO interim guidance\[[@bib3]\]. We arrived in Wuhan on February 2, 2020 and started our support work. The initial night shift schedule was based on a four-day cycle, namely, working from 8 am to 4 pm on the first day, from 4 pm to 12 pm on the second day, from 12 pm to 8 am on the third day, and then taking another day off. All doctors were on duty in accordance with the above rules before the night shift schedule changed. We started implementing the new night shift schedule on Feb 10, 2020, for doctors who are skilled in emergency technique (endotracheal intubation, etc.) or doctors with extensive first aid experience, they only need to work during the day (from 9 am to 6 pm) instead of night shift. Meanwhile, the new night shift schedule of other doctors took a six-day cycle, working from 8 am to 2 pm on the first day, from 2 pm to 8 pm on the second day, from 8 pm to 12 pm on the third day, from 12 pm to 8 am on the fourth day, and then had two days off. The night shift schedule of nurses took a six-day cycle, working from 8 am to 2 pm on the first day, from 2 pm to 8 pm on the second day, from 8 pm to 12 pm on the third day, and from 12 pm to 8 am on the fourth day, and then had two days off. The nurse\'s night shift schedule had never been changed. So, we divided all patients into two groups: initial period group (admission before Feb 10, 2020) and recent period group (admission after Feb 10, 2020). Laboratory confirmation of SARS-CoV-2 infection was performed by the local health authority.

The Ethics Commission of the First Affiliated Hospital of Guangzhou Medical University approved this study (IRB:202051). Written informed consent was waived due to the rapid emergence of this infectious disease.

2.2. Data collection {#sec2.2}
--------------------

We reviewed clinical electronic medical records, nursing records, laboratory findings, and radiological examinations for all patients with laboratory confirmed SARS-CoV-2 infection. The admission data of these patients were collected.

2.3. Outcomes {#sec2.3}
-------------

The primary outcome was the mortality from hospital admission to the cut off date. Since the Medical team of Guangzhou Medical University to assist Wuhan completed the mission and returned to Guangzhou on April 8, the cut-off date was Apr 7, 2020. Sepsis and septic shock were defined according to the 2016 Third International Consensus Definition for Sepsis and Septic Shock\[[@bib4]\]. Secondary infection was diagnosed when patients showed clinical symptoms or signs of pneumonia or bacteremia and a positive culture of a new pathogen was obtained from lower respiratory tract specimens (qualified sputum, endotracheal aspirate, or bronchoalveolar lavage fluid) or blood samples after admission\[[@bib4]\]. Acute kidney injury was diagnosed according to the KDIGO clinical practice guidelines\[[@bib5]\] and acute respiratory distress syndrome (ARDS) was diagnosed according to the Berlin Definition\[[@bib6]\]. The illness severity of COVID-19 was defined according to the Chinese management guideline for COVID-19 (version 7.0)\[[@bib7]\].

2.4. Statistical analysis {#sec2.4}
-------------------------

The purpose of this study is to explore the relationship between the improved night shift schedule and the mortality of critically ill patients with COVID-19. There were, therefore, no formal hypotheses being implemented to drive the sample size calculation and we included the maximum number of patients who met the inclusion criteria.

We expressed descriptive data as mean (SD) or median (IQR) for continuous variables and number (%) for categorical variables. We assessed differences between initial period and recent period using two-sample t test or Wilcoxon rank-sum test depending on parametric or nonparametric data for continuous variables and Fisher's exact test for categorical variables. Cox proportional hazard ratio (HR) models were used to determine HRs and 95% CIs between individual factors on mortality. Survival curves were developed using the Kaplan-Meier method with log-rank test. Time to events (death) were defined as the time from hospital admission to events.

Tests were two-sided with significance set at α less than 0.05. The SPSS 16.0 software (IBM SPSS) was applied for all analyses.

3. Results {#sec3}
==========

A total of 75 patients were included in this study ([figure 1](#fig1){ref-type="fig"} ). Among them, 45 cases were admitted before Feb 10, 2020 and 30 cases were admitted after Feb 10, 2020. The average age of all patients was 66 years (IQR 59-71), with 78.7% males ([table 1](#tbl1){ref-type="table"} ). There was no significant difference in age between the two groups. Nearly half (48%) of patients had hypertension, while 17.3% of patients had coronary heart disease. There was no significant difference in the prevalence of hypertension and coronary heart disease between the two groups ([table 1](#tbl1){ref-type="table"}). In terms of laboratory findings, the level of hemoglobin, lactate dehydrogenase and high-sensitive cardiac troponin I of Initial period group were significantly higher than those of recent period group ([table 1](#tbl1){ref-type="table"}). There was no significant difference in other laboratory findings between the two groups. All patients had bilateral infiltrates on chest x-ray. The most common symptoms were cough (70.7%), dyspnea (57.3%) and fatigue (54.7%). The oxygenation indexes of the two groups were 129.8 (SD 53.1) and 161.8 (SD 75.1), but the difference was not statistically significant. 71 (94.7%) patients received antibiotics and 63 (84%) received antivirals ([table 2](#tbl2){ref-type="table"} ). 63 (84%) patients were treated with high-flow nasal cannula, seven (9.3%) with extracorporeal membrane oxygenation (ECMO), 20 (26.7%) patients were treated with continuous renal replacement therapy. There was no significant difference in the proportion of invasive mechanical ventilation (IMV) and non-invasive mechanical ventilation (NIMV) between the two groups ([table 2](#tbl2){ref-type="table"}).Figure 1Study flow diagram.Figure 1Table 1Demographic, clinical, laboratory, and radiographic findings of patients on admission.Table 1Initial periodRecent period (n=30)All patientsP value(n=45)(n=75)**Demographics and clinical characteristics**Age, years65 (60-70)65.6 (13.9)66 (59-71)0.372Sex0.818 Male35 (77.8%)24 (80%)59 (78.7%) Female10 (22.2%)6 (20%)16 (21.3%)Chronic medical illness Hypertension22 (48.9%)14 (46.7%)36 (48%)0.850 Coronary heart disease10 (22.2%)3 (10%)13 (17.3%)0.171 Cerebrovascular disease4 (8.9%)4 (13.3%)8 (10.7%)0.819 Diabetes10 (22.2%)5 (16.7%)15 (20%)0.556 Chronic obstructive lung disease2 (4.4%)1 (3.3%)3 (4%)1 Chronic liver disease1 (2.2%)01 (1.3%)1 Carcinoma3 (6.7%)2 (6.7%)5 (6.7%)1 Gastrointestinal ulcer1 (2.2%)01 (1.3%)1Current smoker7 (15.6%)4 (13.3%)11 (14.7%)1Respiratory rate \>24 breaths per min13 (28.9%)14 (46.7%)27 (36%)0.116Pulse ≥125 beats per min2 (4.4%)02 (2.7%)0.514Fever (temperature ≥37.3°C)17 (37.8%)7 (23.3%)24 (32%)0.189Cough36 (80%)17 (56.7%)53 (70.7%)0.03Sputum27 (60%)10 (33.3%)37 (49.3%)0.024Myalgia10 (22.2%)4 (13.3%)14 (18.7%)0.333Fatigue30 (66.7%)11 (36.7%)41 (54.7%)0.011Nausea or vomiting1 (2.2%)3 (10%)4 (5.3%)0.345Pharyngalgia3 (6.7%)03 (4%)0.4Headache3 (6.7%)1 (3.3%)4 (5.3%)0.916Dyspnea28 (62.2%)15 (50%)43 (57.3%)0.294Nasal discharge2 (4.4%)02 (2.7%)0.514General malaise14 (31.1%)4 (13.3%)18 (24%)0.077Diarrhea2 (4.4%)1 (3.3%)3 (4%)1**Oxygenation index**129.8 (53.1)161.8 (75.1)145.8 (66.1)0.161**Laboratory findings**White blood cell count, × 10⁹ per L8.1 (5.5-10.9)8.8 (5.7-13.1)8.2 (5.8-11.6)0.503Lymphocyte count, × 10⁹ per L0.6 (0.4-1.0)0.6 (0.4-0.9)0.6 (0.4-0.9)0.837Hemoglobin, g/dL134.0 (124.5-150.0)115.8 (26.3)128.9 (23.3)\<0.001Platelet count, × 10⁹ per L174.6 (79.0)194.8 (88.1)182.7 (82.8)0.305Albumin, g/L28.5 (4.0)29.5 (5.8)28.8 (24.8-32.2)0.677ALT, U/L37.0 (26.5-56.5)36.0 (30.0-59.5)37 (27-57)0.829Lactate dehydrogenase, U/L548 (380-715)381.0 (246.0-542.5)472.0 (332.5-627.3)0.010Creatinine, μmol/l73.8 (62.9-88.0)76.9 (61.1-98.3)74.6 (62.4-88.9)0.869CRP, mg/L70.5 (34.6-115.7)55.9 (31.4-109.7)67.6 (33.8-111.2)0.460High-sensitive cardiac troponin I, ng/mL30.7 (11.1-285.9)9.0 (5.6-45.7)17.5 (7.4-93.2)0.010Prothrombin time, s14.2 (13.0-16.0)14.0 (12.7-15.4)14.2 (13.0-15.6)0.408D-dimer, μg/L0.455 ≤0.59 (20%)4 (13.3%)13 (17.3%) \>0.536 (80%)26 (86.7%)62 (82.7%)Procalcitonin, ng/mL0.2 (0.1-0.4)0.2 (0.1-0.4)0.2 (0.1-0.4)0.661BNP, pg/mL91.1 (44.2-146.3)99.8 (30.8-225.7)93.4 (37.9-185.9)0.956**Imaging features**Bilateral pulmonary infiltration45 (100%)30 (100%)75 (100%)\--[^1]Table 2Treatments and outcomes.Table 2Initial period (n=45)Recent period (n=30)All patients (n=75)P value**Treatments**Antibiotics44 (97.8%)27 (90%)71 (94.7%)0.345Antiviral treatment40 (88.9%)23 (76.7%)63 (84%)0.274Corticosteroids39 (86.7%)21 (70%)60 (80%)0.077Intravenous immunoglobin33 (73.3%)20 (66.7%)53 (70.7%)0.534High-flow nasal cannula oxygen therapy39 (86.7%)24 (80%)63 (84%)0.653Invasive mechanical ventilation44 (97.8%)25 (83.3%)69 (92%)0.068Non-invasive mechanical ventilation25 (55.6%)12 (40%)42 (56%)0.187ECMO3 (6.7%)4 (13.3%)7 (9.3%)0.571CRRT15 (33.3%)5 (16.7%)20 (26.7%)0.110**Prognosis**Discharge from hospital7 (15.6%)14 (46.7%)21 (28%)0.003Death35 (77.8%)11 (36.7%)46 (61.3%)\<0.001Remained in hospital3 (6.7%)5 (16.7%)8 (10.7%)0.321**Outcome**ICU length of stay, days9 (6-15)12.0 (4.5-17.5)9.5 (6.0-15.8)0.791Time from illness onset to ICU admission, days18 (12-27)25.7 (14.8)20 (13-29)0.081Time from illness onset to initiation of IMV, days18 (12-23)17.0 (11.5-30.5)17.5 (12.0-24.8)0.960Time from illness onset to initiation of NIMV, days14.0 (11.5-21.5)13.5 (8.6)13.5 (10.8-19.3)0.270**Complications**Septic shock8 (17.8%)6 (20%)14 (18.7%)0.809Secondary infection28 (62.2%)15 (50%)43 (57.3%)0.294Acute kidney failure14 (31.1%)2 (6.7%)16 (21.3%)0.011DIC3 (6.7%)2 (6.7%)5 (6.7%)1pneumothorax10 (22.2%)4 (13.3%)14 (18.7%)0.333Stress ulcer2 (4.4%)2 (6.7%)4 (5.3%)1ARDS8 (17.8%))3 (10%)11 (14.7%)0.549DVT2 (4.4%)1 (3.3%)3 (4%)1Respiratory failure14 (31.1%)8 (26.7%)22 (29.3%)0.679Sepsis9 (20%)7 (23.3%)16 (21.3%)0.730Acidosis5 (11.1%)05 (6.7%)0.156Viral myocarditis5 (11.1%)05 (6.7%)0.156Hypoproteinemia7 (15.6%)2 (6.7%)9 (12%)0.425[^2]

21 patients (28%) were discharged before the cut off date. The difference in mortality between the two groups was significant, 77.8% and 36.7%, respectively. The number of patients in the two groups who were still in hospital before the deadline was 3 and 5 respectively. The median time of intensive care unit (ICU) length of stay was 9.5 days (IQR 6.0-15.8). There was no significant difference in ICU length of stay between the two groups ([table 2](#tbl2){ref-type="table"}). The median time from illness onset to ICU admission was 20 days (IQR 13-29), the median time from illness onset to initiation of IMV was 17.5 days (IQR 12.0-24.8), the median time from illness onset to initiation of NIMV was 13.5 days (IQR 10.8-19.3). The most common complications was secondary infection (57.3%). The frequency of acute kidney failure were higher in initial period group than recent period ([table 2](#tbl2){ref-type="table"}).

In univariable analysis, odds of in-hospital death was higher in Initial period group ([table 3](#tbl3){ref-type="table"} ). Leukocytosis, high-sensitive cardiac troponin I and d-dimer were also associated with death ([table 3](#tbl3){ref-type="table"}). In the multivariable Cox proportional hazard ratio models, we found that Leukocytosis at admission and admitted to hospital before the new night shift schedule were associated with increased odds of death ([table 3](#tbl3){ref-type="table"}). For the primary outcome, among 75 critically ill patients with SARS-CoV-2 infection, 46 (61.3%) patients had died before the cut off date, and the median duration from hospital admission to death was 26.0 days (IQR 16.1--35.9) in Initial period group ([figure 2](#fig2){ref-type="fig"} ).Table 3Risk factors associated with in-hospital death.Table 3Univariable HRp valueMultivariable HRp value(95% CI)(95% CI)**Demographics and clinical characteristics**Age, years \<651 (ref)\-- ≥651.56 (0.86-2.82)0.145Male sex (vs female)1.17 (0.57-2.44)0.669Current smoker (vs nonsmoker)1.76 (0.83-3.71)0.139Comorbidity present (vs not present)1.06 (0.56-2.01)0.862 Chronic obstructive pulmonary disease2.85 (0.87-9.31)0.084 Coronary heart disease0.85 (0.40-1.83)0.682 Diabetes1.23 (0.59-2.56)0.581 Hypertension1.36 (0.75-2.45)0.310**Laboratory findings**White blood cell count, × 10⁹ per L \<40.46 (0.11-1.95)0.2880.61 (0.08-4.84)0.637 4--101 (ref)\--1 (ref) \>101.95 (1.07-3.53)0.0282.29 (1.10-4.78)0.027Lymphocyte count, × 10⁹ per L \<0.81.53 (0.76-3.10)0.233 0.8--3.51 (ref)\-- \>3.55.28 (0.65-42.66)0.118Platelet count, × 10⁹ per L \<1001.36 (0.65-2.83)0.416 100--3001 (ref)\-- \>3000.96 (0.29-3.13)0.943AST, U/L ≤401 (ref)\-- \>401.26 (0.69-2.30)0.452ALT, U/L ≤401 (ref)\-- \>400.87 (0.48-1.55)0.628Creatinine, μmol/l ≤1331 (ref)\-- \>1330.39 (0.05-2.82)0.350Lactate dehydrogenase, U/L ≤2451 (ref)\-- \>2451.89 (0.59-6.11)0.287High-sensitive cardiac troponin I, ng/mL ≤281 (ref)\--1 (ref) \>282.06 (1.06-4.01)0.0331.48 (0.72-3.05)0.287Prothrombin time, s ≤161 (ref)\-- \>161.87 (0.94-3.71)0.075D-dimer, μg/L ≤0.51 (ref)\--1 (ref)\-- \>0.52.88 (1.12-7.42)0.0291.73 (0.59-5.13)0.321Procalcitonin, ng/mL ≤0.51 (ref)\-- \>0.51.60 (0.70-3.66)0.266**Others**IMV (vs NIMV only)3.41 (0.82-14.16)0.092NIMV (vs without NIMV)1.33 (0.74-2.39)0.345Period of hospital admission Recent period1 (ref)\--1 (ref)\-- Initial period2.42 (1.23-4.77)0.0112.85 (1.29-6.29)0.010[^3]Figure 2Survival of critically ill patients with COVID-19.Figure 2

4. Discussion {#sec4}
=============

The results of this study show that the mortality before and after the implementation of the new night shift schedule was 77.8% and 33.3%, respectively, and the mortality of recent period group has dropped significantly. To our knowledge, this is the first study to explore the relationship between the improved night shift schedule and the mortality of critically ill patients with COVID-19.

In the early stage of the outbreak of COVID-19, due to the huge number of patients, medical institutions at all levels were overloaded, and the sleep time of medical staff could not be guaranteed. At the same time, due to the unknown and highly infectious nature of SARS-CoV-2, the above two factors make the mental state of medical workers prone to problems. Previous studies reported that researchers used questionnaires to collect the "psychological stress" of medical staff and college students in various provinces in China during the epidemic, it was found that the \"psychological stress\" of first-line medical staff was significantly higher than that of college students\[[@bib1]\]. Another study also showed that the somatization, depression, anxiety, and terror of first-line medical staff were more serious than the control group, and the sleep quality was also worse, the incidence of moderate and severe insomnia were 61.67% and 26.67%, respectively\[[@bib2]\].

In order to ensure adequate rest for the medical staff who have mastered the core technology, we have implemented the new night shift schedule, that is, the skilled medical staff only need to go to the day shift, reducing or even canceling their night shift, thus ensuring their sleep time and mental state during the day work. It is reported that the quality of sleep of medical staff has an important impact on the daily clinical work\[[@bib8], [@bib9]\]. A study of 289 night shift nurses showed that more than half (56%) of the nurses had sleep deprivation, and these nurses were more likely to make errors in nursing work\[[@bib8]\]. A review also shows that sleep deprivation not only affects clinicians' memory, but also worsens clinicians' decision-making ability, concentration, and reaction time\[[@bib9]\]. It is worth noting that sleep deprivation and frequent night shifts also increase the risk of medical staff contracting SARS-CoV-2\[[@bib10]\].

In addition, the new night shift schedule ensures the continuity of treatment. For patients with serious illness and rapid progress, medical staff need to pay close attention to prepare for emergency events. Before the implementation of the new night shift schedule, medical staff would work in three shifts or even four shifts per day. Unstable working hours and changes in sleep rhythm prevented doctors who knew the condition of these patients from maintaining relatively continuous medical care. After the implementation of the new night shift schedule, these doctors only need to go to the day shift, and their working hours have been greatly extended, while ensuring sufficient sleep time, thereby improving the quality of clinical work.

Consistent with the results of our study, many articles reported that severe COVID-19 patients had leukocytosis, and leukocytosis is associated with patients\' poor prognosis\[[@bib11], [@bib12], [@bib13], [@bib14]\]. In this study, the increase in D-dimer and high-sensitive cardiac troponin I was associated with poor prognosis, reflecting the direct effect of patients\' coagulation function and cardiac dysfunction on mortality, consistent with previous reports\[[@bib13], [@bib15]\].

This study has several limitations. First, we did not evaluate the mental health status and sleep quality of medical staff, however, according to the frontline medical staff\'s self-prosecution, their mental state has been greatly improved after the night shift schedule was changed. Secondly, since this study is a retrospective study, we cannot collect this information of sequential organ failure assessment (SOFA) score and acute physiology and chronic health evaluation II (APACHE II) score.

5. Conclusions {#sec5}
==============

In conclusion, shift arrangement of medical staff are associated with the mortality of critically ill patients with COVID-19. The new night shift schedule might improve the continuity of treatment, thereby improving the overall quality of medical work and reducing the mortality of critically ill patients.
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COVID-19Corona Virus Disease 2019SARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2IRBinstitutional review boardALTalanine aminotransferaseASTaspartate aminotransferaseCRPc-reactive proteinBNPbrain natriuretic peptideDICdisseminated intravascular coagulationARDSacute respiratory distress syndromeDVTdeep venous thrombosisECMOextracorporeal membrane oxygenationCRRTcontinuous renal replacement therapyIMVinvasive mechanical ventilationNIMVnon-invasive mechanical ventilationICUintensive care unitSOFAsequential organ failure assessmentAPACHE IIacute physiology and chronic health evaluation IISDstandard deviationIQRinterquartile rangeCIconfidence intervalHRhazard ratio.

Appendix A. Supplementary data {#appsec1}
==============================

The following is the Supplementary data to this article:
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[^1]: Data are mean (SD), median (IQR) or n (%). ALT, alanine aminotransferase; CRP, c-reactive protein; BNP, brain natriuretic peptide.

[^2]: Data are mean (SD), median (IQR) or n (%). ECMO, extracorporeal membrane oxygenation; CRRT, continuous renal replacement therapy; ICU, intensive care unit; IMV, invasive mechanical ventilation; NIMV, non-invasive mechanical ventilation; DIC, disseminated intravascular coagulation; ARDS, acute respiratory distress syndrome; DVT, deep venous thrombosis.

[^3]: CI, confidence interval; HR, hazard ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; IMV, invasive mechanical ventilation; NIMV, non-invasive mechanical ventilation.
